vs
IMAX（IMAX）与PROCEPT BioRobotics Corp（PRCT）财务数据对比。点击上方公司名可切换其他公司
IMAX的季度营收约是PROCEPT BioRobotics Corp的1.5倍（$125.2M vs $83.1M），IMAX净利率更高（0.5% vs -38.1%，领先38.6%），IMAX同比增速更快（35.1% vs 20.2%），过去两年IMAX的营收复合增速更高（25.8% vs 24.8%）
IMAX公司是加拿大的影视放映技术企业，1967年创立于蒙特利尔，总部位于多伦多地区，在纽约、洛杉矶均设有业务点。核心业务包括IMAX摄影机与放映系统的设计制造，同时面向全球合作影院提供影片开发、制作、后期及发行服务，是沉浸式观影技术领域的领先企业。
PROCEPT BioRobotics是一家专注于研发和商业化泌尿外科手术机器人解决方案的医疗科技企业，其旗舰AquaBeam系统可为良性前列腺增生患者提供图像引导微创治疗，服务覆盖北美、欧洲等地区的医疗机构与患者。
IMAX vs PRCT — 直观对比
营收规模更大
IMAX
是对方的1.5倍
$83.1M
营收增速更快
IMAX
高出14.9%
20.2%
净利率更高
IMAX
高出38.6%
-38.1%
两年增速更快
IMAX
近两年复合增速
24.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $125.2M | $83.1M |
| 净利润 | $637.0K | $-31.6M |
| 毛利率 | 57.6% | 64.9% |
| 营业利润率 | 19.3% | -4.1% |
| 净利率 | 0.5% | -38.1% |
| 营收同比 | 35.1% | 20.2% |
| 净利润同比 | -88.0% | -27.9% |
| 每股收益（稀释后） | $0.02 | $-0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IMAXPRCT
| Q1 26 | — | $83.1M | ||
| Q4 25 | $125.2M | $76.4M | ||
| Q3 25 | $106.7M | $83.3M | ||
| Q2 25 | $91.7M | $79.2M | ||
| Q1 25 | $86.7M | $69.2M | ||
| Q4 24 | $92.7M | $68.2M | ||
| Q3 24 | $91.5M | $58.4M | ||
| Q2 24 | $89.0M | $53.4M |
净利润IMAXPRCT
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $637.0K | $-29.8M | ||
| Q3 25 | $20.7M | $-21.4M | ||
| Q2 25 | $11.3M | $-19.6M | ||
| Q1 25 | $2.3M | $-24.7M | ||
| Q4 24 | $5.3M | $-18.9M | ||
| Q3 24 | $13.9M | $-21.0M | ||
| Q2 24 | $3.6M | $-25.6M |
毛利率IMAXPRCT
| Q1 26 | — | 64.9% | ||
| Q4 25 | 57.6% | 60.6% | ||
| Q3 25 | 63.1% | 64.8% | ||
| Q2 25 | 58.5% | 65.4% | ||
| Q1 25 | 61.4% | 63.9% | ||
| Q4 24 | 52.2% | 64.0% | ||
| Q3 24 | 55.8% | 63.2% | ||
| Q2 24 | 49.4% | 59.0% |
营业利润率IMAXPRCT
| Q1 26 | — | -4.1% | ||
| Q4 25 | 19.3% | -40.6% | ||
| Q3 25 | 27.2% | -27.8% | ||
| Q2 25 | 15.6% | -28.0% | ||
| Q1 25 | 19.3% | -39.7% | ||
| Q4 24 | 10.3% | -28.9% | ||
| Q3 24 | 21.2% | -38.4% | ||
| Q2 24 | 3.2% | -50.3% |
净利率IMAXPRCT
| Q1 26 | — | -38.1% | ||
| Q4 25 | 0.5% | -39.1% | ||
| Q3 25 | 19.4% | -25.7% | ||
| Q2 25 | 12.3% | -24.7% | ||
| Q1 25 | 2.7% | -35.8% | ||
| Q4 24 | 5.7% | -27.6% | ||
| Q3 24 | 15.2% | -35.9% | ||
| Q2 24 | 4.0% | -48.0% |
每股收益（稀释后）IMAXPRCT
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.02 | $-0.54 | ||
| Q3 25 | $0.37 | $-0.38 | ||
| Q2 25 | $0.20 | $-0.35 | ||
| Q1 25 | $0.04 | $-0.45 | ||
| Q4 24 | $0.09 | $-0.34 | ||
| Q3 24 | $0.26 | $-0.40 | ||
| Q2 24 | $0.07 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $151.2M | $245.6M |
| 总债务越低越好 | — | $51.7M |
| 股东权益账面价值 | $337.9M | $347.7M |
| 总资产 | $894.0M | $487.1M |
| 负债/权益比越低杠杆越低 | — | 0.15× |
8季度趋势，按日历期对齐
现金及短期投资IMAXPRCT
| Q1 26 | — | $245.6M | ||
| Q4 25 | $151.2M | $286.5M | ||
| Q3 25 | $143.1M | $294.3M | ||
| Q2 25 | $109.3M | $302.7M | ||
| Q1 25 | $97.1M | $316.2M | ||
| Q4 24 | $100.6M | $333.7M | ||
| Q3 24 | $104.5M | $196.8M | ||
| Q2 24 | $91.6M | $214.1M |
总债务IMAXPRCT
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
股东权益IMAXPRCT
| Q1 26 | — | $347.7M | ||
| Q4 25 | $337.9M | $365.9M | ||
| Q3 25 | $349.5M | $380.3M | ||
| Q2 25 | $320.4M | $385.8M | ||
| Q1 25 | $299.5M | $389.2M | ||
| Q4 24 | $299.5M | $402.2M | ||
| Q3 24 | $289.4M | $241.2M | ||
| Q2 24 | $267.2M | $251.8M |
总资产IMAXPRCT
| Q1 26 | — | $487.1M | ||
| Q4 25 | $894.0M | $508.1M | ||
| Q3 25 | $889.6M | $511.5M | ||
| Q2 25 | $868.6M | $513.1M | ||
| Q1 25 | $848.3M | $519.4M | ||
| Q4 24 | $830.4M | $534.0M | ||
| Q3 24 | $847.6M | $374.1M | ||
| Q2 24 | $827.4M | $374.4M |
负债/权益比IMAXPRCT
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $29.4M | — |
| 自由现金流经营现金流 - 资本支出 | $28.0M | — |
| 自由现金流率自由现金流/营收 | 22.3% | — |
| 资本支出强度资本支出/营收 | 1.1% | — |
| 现金转化率经营现金流/净利润 | 46.11× | — |
| 过去12个月自由现金流最近4个季度 | $118.9M | — |
8季度趋势，按日历期对齐
经营现金流IMAXPRCT
| Q1 26 | — | — | ||
| Q4 25 | $29.4M | $-10.3M | ||
| Q3 25 | $67.5M | $-6.6M | ||
| Q2 25 | $23.2M | $-15.0M | ||
| Q1 25 | $7.0M | $-17.0M | ||
| Q4 24 | $11.5M | $-32.4M | ||
| Q3 24 | $35.3M | $-18.8M | ||
| Q2 24 | $35.0M | $-15.7M |
自由现金流IMAXPRCT
| Q1 26 | — | — | ||
| Q4 25 | $28.0M | $-12.2M | ||
| Q3 25 | $64.8M | $-9.5M | ||
| Q2 25 | $20.9M | $-17.8M | ||
| Q1 25 | $5.3M | $-18.8M | ||
| Q4 24 | $6.9M | $-33.6M | ||
| Q3 24 | $34.2M | $-19.0M | ||
| Q2 24 | $33.5M | $-16.8M |
自由现金流率IMAXPRCT
| Q1 26 | — | — | ||
| Q4 25 | 22.3% | -15.9% | ||
| Q3 25 | 60.7% | -11.4% | ||
| Q2 25 | 22.8% | -22.5% | ||
| Q1 25 | 6.1% | -27.2% | ||
| Q4 24 | 7.4% | -49.2% | ||
| Q3 24 | 37.3% | -32.6% | ||
| Q2 24 | 37.6% | -31.4% |
资本支出强度IMAXPRCT
| Q1 26 | — | — | ||
| Q4 25 | 1.1% | 2.4% | ||
| Q3 25 | 2.6% | 3.4% | ||
| Q2 25 | 2.6% | 3.5% | ||
| Q1 25 | 1.9% | 2.7% | ||
| Q4 24 | 5.0% | 1.7% | ||
| Q3 24 | 1.2% | 0.4% | ||
| Q2 24 | 1.8% | 2.0% |
现金转化率IMAXPRCT
| Q1 26 | — | — | ||
| Q4 25 | 46.11× | — | ||
| Q3 25 | 3.27× | — | ||
| Q2 25 | 2.06× | — | ||
| Q1 25 | 2.99× | — | ||
| Q4 24 | 2.16× | — | ||
| Q3 24 | 2.54× | — | ||
| Q2 24 | 9.78× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IMAX
| Technology Sales | $46.6M | 37% |
| Image Enhancement And Maintenance Services | $38.1M | 30% |
| Joint Revenue Sharing Arrangement | $20.4M | 16% |
| Maintenance | $16.3M | 13% |
| Finance Income | $2.8M | 2% |
| Other Content Solutions | $1.6M | 1% |
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
